Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:CEO |
gptkb:Colin_McCracken
|
| gptkbp:foundedYear |
2015
|
| gptkbp:founder |
gptkb:Matthew_Hayes
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
Evonetix
|
| gptkbp:industry |
gptkb:biotechnology
synthetic biology |
| gptkbp:investor |
gptkb:Cambridge_Innovation_Capital
gptkb:Morningside_Ventures gptkb:Providence_Investment_Company gptkb:DCVC |
| gptkbp:mission |
to enable scalable, high-fidelity gene synthesis
|
| gptkbp:numberOfEmployees |
51-100
|
| gptkbp:product |
DNA synthesis platform
|
| gptkbp:technology |
semiconductor-based DNA synthesis
|
| gptkbp:website |
https://www.evonetix.com/
|
| gptkbp:bfsParent |
gptkb:Wellcome_Trust_Sanger_Institute
|
| gptkbp:bfsLayer |
5
|